Vpr Is Preferentially Targeted by CTL During HIV-1 Infection
about
Roles of HIV-1 auxiliary proteins in viral pathogenesis and host-pathogen interactionsMultiplex RT-PCR amplification of HIV genes to create a completely autologous DC-based immunotherapy for the treatment of HIV infectionInfluence of HAART on alternative reading frame immune responses over the course of HIV-1 infectionLoss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4+ T cellsAPOBEC3G-induced hypermutation of human immunodeficiency virus type-1 is typically a discrete "all or nothing" phenomenon.Viral diversity and diversification of major non-structural genes vif, vpr, vpu, tat exon 1 and rev exon 1 during primary HIV-1 subtype C infection.High-avidity, high-IFNγ-producing CD8 T-cell responses following immune selection during HIV-1 infection.Constraints on HIV-1 evolution and immunodominance revealed in monozygotic adult twins infected with the same virusIdentification of cryptic MHC I-restricted epitopes encoded by HIV-1 alternative reading framesImmunoprevalence of the CD4+ T-cell response to HIV Tat and Vpr proteins is provided by clustered and disperse epitopes, respectively.Evasion of cytotoxic T lymphocytes is a functional constraint maintaining HIV-1 Nef expression.Identification of two unique naturally occurring Vpr sequence polymorphisms associated with clinical parameters in HIV-1 chronic infection.Saporin-conjugated tetramers identify efficacious anti-HIV CD8+ T-cell specificities.Arcelis AGS-004 dendritic cell-based immunotherapy for HIV infection.Significant effect of hepatitis C virus specific CTLs on viral clearance in patients with type C chronic hepatitis treated with antiviral agents.An IL-15 dependent CD8 T cell response to selected HIV epitopes is related to viral control in early-treated HIV-infected subjects.The dose-dependent H2O2 stress response promotes increased survival for Schizosaccharomyces pombe cells expressing HIV-1 Vpr.
P2860
Q28286819-162A9D92-19E6-43EC-822F-CD9068E848B8Q28472020-8B02C941-C1AF-4EB9-9592-2300AD999BAEQ28480902-83CF9BA5-AFD7-4B67-B95F-9EF8C81A10E4Q33981572-50929E9F-A8BF-46B4-949D-3730727AEED0Q34211562-F537E3C7-4441-462D-AC52-D5925AE3465FQ34270602-4573C3B4-8198-4763-BD79-712CAC0FB6D1Q35214354-E908FBD1-6A8C-403A-8AAB-50051C97AF97Q36228343-4DB26708-B27A-4215-8790-0CE25856E05DQ36399462-DF3822E7-4EF3-4FC0-B6D3-7AE65D7C3F97Q39933791-046CF06E-DB15-4FFB-BACE-090DA8854434Q40365272-3667BA0A-E432-4BEB-BB1D-1B3BFFAF2229Q40473791-E2DCF39C-461E-4E24-8CA8-8B7255A27A87Q41919259-998A48D4-B810-4440-8848-4A1682C9ABD1Q44606374-5E91ACBD-6C68-4AB0-91B1-96E87437C412Q45399081-67074785-5535-4966-8AC5-272DFFF183A7Q51971392-26E67A55-83F0-473E-81C8-3B74BF75711AQ53582168-58AFE1AF-0EB5-4F87-9262-BB553240F0C7
P2860
Vpr Is Preferentially Targeted by CTL During HIV-1 Infection
description
article
@en
im September 2001 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у вересні 2001
@uk
name
Vpr Is Preferentially Targeted by CTL During HIV-1 Infection
@en
Vpr Is Preferentially Targeted by CTL During HIV-1 Infection
@nl
type
label
Vpr Is Preferentially Targeted by CTL During HIV-1 Infection
@en
Vpr Is Preferentially Targeted by CTL During HIV-1 Infection
@nl
prefLabel
Vpr Is Preferentially Targeted by CTL During HIV-1 Infection
@en
Vpr Is Preferentially Targeted by CTL During HIV-1 Infection
@nl
P2093
P1476
Vpr is preferentially targeted by CTL during HIV-1 infection
@en
P2093
B D Walker
E S Rosenberg
HIV Study Collaboration
M N Phillips
P J Goulder
R L Eldridge
P304
P356
10.4049/JIMMUNOL.167.5.2743
P407
P577
2001-09-01T00:00:00Z